309 related articles for article (PubMed ID: 17559988)
1. Meningococcal carriage and immunity in western Burkina Faso, 2003.
Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
[TBL] [Abstract][Full Text] [Related]
2. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
[TBL] [Abstract][Full Text] [Related]
4. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
[TBL] [Abstract][Full Text] [Related]
5. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
[TBL] [Abstract][Full Text] [Related]
6. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.
Trotter CL; Yaro S; Njanpop-Lafourcade BM; Drabo A; Kroman SS; Idohou RS; Sanou O; Bowen L; Findlow H; Diagbouga S; Gessner BD; Borrow R; Mueller JE
PLoS One; 2013; 8(2):e55486. PubMed ID: 23457471
[TBL] [Abstract][Full Text] [Related]
8. Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso.
Mueller JE; Yaro S; Madec Y; Somda PK; Idohou RS; Lafourcade BM; Drabo A; Tarnagda Z; Sangaré L; Traoré Y; Fontanet A; Gessner BD
Trop Med Int Health; 2008 Dec; 13(12):1543-52. PubMed ID: 18983283
[TBL] [Abstract][Full Text] [Related]
9. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005.
Adjogble KL; Lourd M; Njanpop-Lafourcade BM; Traoré Y; Hlomaschi AF; Amegatse KA; Agbenoko K; Sanou O; Sita K; Mueller JE; Gessner BD
Vaccine; 2007 Sep; 25 Suppl 1():A47-52. PubMed ID: 17517455
[TBL] [Abstract][Full Text] [Related]
11. Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006.
Yaro S; Njanpop-Lafourcade BM; Drabo A; Idohou RS; Kroman SS; Sanou O; Traoré Y; Sangaré L; Diagbouga SP; Koeck JL; Borrow R; Gessner BD; Mueller JE
J Infect Dis; 2014 Apr; 209(8):1241-50. PubMed ID: 24277740
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso.
Tall H; Yaro S; Kpoda HB; Ouangraoua S; Trotter CL; Njanpop Lafourcade BM; Findlow H; Bai X; Martin C; Nwakamma I; Ouedraogo JB; Gessner BD; Borrow R; Mueller JE
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S540-6. PubMed ID: 26553686
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
14. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
[TBL] [Abstract][Full Text] [Related]
15. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
Vogel G
Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
[No Abstract] [Full Text] [Related]
16. Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.
Mueller JE; Yaro S; Njanpop-Lafourcade BM; Drabo A; Idohou RS; Kroman SS; Sanou O; Diagbouga S; Traoré Y; Sangaré L; Borrow R; Gessner BD
J Infect Dis; 2011 Dec; 204(11):1787-95. PubMed ID: 21998478
[TBL] [Abstract][Full Text] [Related]
17. Emergence of W135 meningococcal meningitis in Ghana.
Forgor AA; Leimkugel J; Hodgson A; Bugri A; Dangy JP; Gagneux S; Smith T; Pluschke G
Trop Med Int Health; 2005 Dec; 10(12):1229-34. PubMed ID: 16359402
[TBL] [Abstract][Full Text] [Related]
18. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
[TBL] [Abstract][Full Text] [Related]
19. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt.
Zombré S; Hacen MM; Ouango G; Sanou S; Adamou Y; Koumaré B; Kondé MK
Vaccine; 2007 Sep; 25 Suppl 1():A69-71. PubMed ID: 17630052
[TBL] [Abstract][Full Text] [Related]
20. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.
Decosas J; Koama JB
Lancet Infect Dis; 2002 Dec; 2(12):763-5. PubMed ID: 12467693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
